Imaging Nuclear Medicine Radiopharmaceuticals 
AuntMinnie
APRIL 15, 2024
Total nuclear medicine patient study volumes decreased by 5.7% Specifically considering cardiovascular nuclear medicine procedures, total procedures have decreased by 7.1% million nuclear medicine patient studies performed. Davin Korstjens of IMV Medical Information Division. Of these, 5.8 Nonhospitals 2.5%
AuntMinnie
FEBRUARY 5, 2025
Personalized medicine is rapidly evolving in cancer theranostics, with technology now available that allows clinicians to optimize doses of radiopharmaceuticals on an individual patient level, according to experts. and Europe, with more in development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
NOVEMBER 7, 2024
Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures.
AuntMinnie
MARCH 26, 2025
A select group of eight radionuclides holds hope for an emerging cancer treatment in nuclear medicine called targeted alpha therapy (TAT). Ultimately, most hospitals conducting trials receive doses of these eight radionuclides from upstream radiopharmaceutical production facilities, with U.S.
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
AuntMinnie
MARCH 5, 2025
It's been really neat for us to not only have the beneficial reuse, where we're offsetting the cost of the American taxpayer, but you're actually seeing something pretty cool come out of it in nuclear medicine space, explained OREM manager Jay Mullis. Canada, Australia, and in Europe. recently launched an effort similar to OREM's.
AuntMinnie
OCTOBER 14, 2024
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new guidelines on their use can help pave the way to improved outcomes for patients, experts noted in a recent article. The article was published October 10 in the Journal of Nuclear Medicine. The full article is available here.
Expert insights. Personalized for you.
279 
Let's personalize your content